Xconomy

AUGUST 19, 2016

And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. Talk about sacrifice. If drug approval were an Olympic sport, rejections would also be high drama. Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data.

Technical Review 40

Technical Review Patents .Net Study 40

Xconomy

AUGUST 26, 2016

Its latest hike has brought the two-pack of injectors to more than $600, according to the Wall Street Journal. Frank Vinluan has more on Novan, which relied on a variety of high net worth individuals, rather than venture firms, to get to this point.

Pricing 40

Pricing Thousand Oaks Startup Research 40

Xconomy

NOVEMBER 4, 2016

—Doctors testing a combination of two immunotherapy checkpoint inhibitors, nivolumab (Opdivo) and ipilimumab (Yervoy), reported in the New England Journal of Medicine that two melanoma patients in the trial died of heart problems. —Several other biotechs released ASH abstract data, and the net effect was a drop in most stocks.

Research 40

Research Report Pricing Journal 40

SoCal Delicious

OCTOBER 8, 2012

Professor Journal. Student Journal. Mark Holtzman for The Wall Street Journal. Mark Holtzman for The Wall Street Journal). edition of The Wall Street Journal, with the headline: Tech Titans Hit the Beach. Downtown San Diego Condos. MarketWatch. MarketWatch. AllThingsDigital. AllThingsDigital.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44